Delivery Order SPE2DB20D6037-SPE2DB21FC9TV
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the provision of various pharmaceutical products and medical supplies. The contract has a ceiling value of $1,304.67 and a completion date of May 22, 2024. This order was issued under DMS Pharmaceutical's existing indefinite delivery contract (IDC) with DLA, valued at up to $499,999,999, which supports the recurring medical supply needs of...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the provision of a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide. The contract, valued at up to $21,322.56, has an ultimate completion date of August 31, 2023. DMS Pharmaceutical Group is an established supplier of branded and generic prescription drugs,...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide. The contract, valued up to $1,543.92, covers the delivery of various medications including branded and generic prescription drugs, over-the-counter products, biologics, and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a range of pharmaceutical products and medical supplies to support military health facilities. The contract has a ceiling value of $1,381.20 and runs through June 28, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA's...
- The U.S. Department of Defense, through the Defense Logistics Agency (DLA), awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the procurement of pharmaceutical products and medical supplies. The $17,795.10 contract has a period of performance through March 14, 2024. This order is part of a larger indefinite delivery, indefinite quantity (IDIQ) contract valued up to $4,999,999 that DMS Pharmaceutical Group holds with the DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a wide range of pharmaceutical products and medical supplies. This order, valued at $2,319.51, is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group that has a ceiling value of up to $499,999,999. The IDC, under the DLA's SPE2DB program, allows the agency to issue delivery orders for a comprehensive...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for $11,478.20. The contract is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with DLA valued up to $499,999,999, which provides a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of Department of Defense (DoD) healthcare...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide. The contract, valued at $1,221.12, is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which has a ceiling value of up to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of a variety of pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The contract, valued at $7,104.00, has an ultimate completion date of August 28, 2024. This delivery order falls under a larger indefinite...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a broad range of pharmaceutical products and medical supplies to military health facilities worldwide. The contract, valued up to $3,112.22, has no set-aside designation and runs through April 10, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that offers brand-name and generic...
- SPE2DB20D6037Indefinite Delivery Contract
- SPE2DB20D6037-SPE2DB21FC9TVDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of a wide range of pharmaceutical products and medical supplies to military health facilities. The contract, valued at $1,003.33, supports the DLA's Prime Vendor Pharmacy program and covers the recurring medical supply needs of the Department of Defense (DoD) healthcare system. DMS Pharmaceutical Group provides both common and specialized medications, including prescription drugs, over-the-counter products, biologics, and medical consumables, to fulfill diverse medical requirements across various DoD facilities. This delivery order contract is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA, which allows for the issuance of firm fixed-price orders for pharmaceutical items through December 31, 2025. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 12/1/20 |